COTQF (Cotinga Pharmaceuticals) Earnings Yield (Joel Greenblatt) % : -109.89% (As of Jan. 2020)

Cotinga Pharmaceuticals Earnings Yield (Joel Greenblatt) % Chart

Cotinga Pharmaceuticals Annual Data
	Trend	Apr10	Apr11	Apr12	Apr13	Apr14	Apr15	Apr16	Apr17	Apr18	Apr19
Earnings Yield (Joel Greenblatt) %		Get a 7-Day Free Trial					-14.12	-7.55	-11.35	-76.92	-140.85

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Earnings Yield (Joel Greenblatt) %	Get a 7-Day Free Trial															-114.94	-140.85	-68.03	-71.94	-109.89

Competitive Comparison of Cotinga Pharmaceuticals's Earnings Yield (Joel Greenblatt) %

For the Biotechnology subindustry, Cotinga Pharmaceuticals's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cotinga Pharmaceuticals's Earnings Yield (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's Earnings Yield (Joel Greenblatt) % falls into.

Cotinga Pharmaceuticals Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Cotinga Pharmaceuticalss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Apr. 2019 is calculated as

Cotinga Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jan. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.81 Mil.

Cotinga Pharmaceuticals  (OTCPK:COTQF) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.

Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.

Cotinga Pharmaceuticals Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals Business Description